Malaysia is allowing Sinovac for adolescents aged 12 and above and Health Director-General Tan Sri Dr Noor Hisham Abdullah says the matter was agreed at the 364th Meeting of the Drug Control Authority (DCA) held today.
“However, the DCA recommends that the use of Sinovac among adolescents aged 12 to 17 years, for the moment, is given priority to adolescents without comorbidities and who have allergies or are not suitable to receive the Comirnaty vaccine.
“This is the second Covid-19 vaccine approved for use on adolescents after a similar approval was given to the Comirnaty vaccine produced by Pfizer BioNTech last June,“ he says.
